Hot Topics in HIV Management: Challenging Clinical Cases Featuring Wheel of Knowledge

1.50 CME
1.50 CPE
90 MINS
$0 FEE
SAVE
J376

Overview

Provider Statements

This continuing medical education activity is provided by Purdue U.

This continuing pharmacy education activity is provided by Vindico Medical Education.


Support Statement

This activity is supported by an educational grant from ViiV Healthcare, a joint venture of GlaxoSmithKline, Pfizer, and Shionogi.


Target Audience

The intended audience for this activity is infectious disease specialists, pharmacists, and other health care professionals involved in the treatment of patients with HIV.


Learning Objectives

Upon successful completion of this activity, participants should be better able to:

Physicians:

  • Apply updated evidence-based guidelines and recommendations when selecting initial treatment for patients with HIV.
  • Select and optimize HIV treatment regimens based on clinical safety and efficacy, propensity for resistance, and patient characteristics.
  • Consider existing comorbidities and conditions, as well as patient preferences, when selecting HIV treatment regimens to improve outcomes and increase adherence and compliance to therapy.
  • Implement effective switching strategies, as necessary, in patients who have become virologically resistant to therapy, experience drug interactions/toxicity, or who have become nonadherent.

Pharmacists:

  • Apply updated evidence-based guidelines and recommendations when evaluating initial treatment options for patients with HIV.
  • Evaluate HIV treatment regimens based on their clinical safety and efficacy, propensity for resistance, and patient characteristics.
  • Consider existing comorbidities and conditions, as well as patient preferences, when assessing HIV treatment regimens to improve outcomes, as well as increase adherence and compliance to therapy.
  • Assess effective switching strategies in patients who have become virologically resistant to therapy, experience drug interactions/toxicity, or who have become nonadherent.

Activity Chair

Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, MA


Faculty

Richard A. Elion, MD
Clinical Professor of Medicine
George Washington University School of Medicine
Co-Director, HIV/HCV Treatment and Research Program
Providence Hospital
Washington, DC

Joseph J. Eron, Jr., MD
Professor of Medicine
Division of Infectious Diseases
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, NC

Brian R. Wood, MD
Physician, Madison Clinic at Harborview
Faculty Trainer, Mountain West AIDS Education and Training Center (MWAETC)
Medical Director, MWAETC HIV Telehealth Programs
Associate Professor of Medicine, Allergy and Infectious Diseases
University of Washington Medicine
Seattle, WA


Reviewer

Jennifer Cocohoba, PharmD, MAS, BCPS, AAHIVP


Accreditation

Purdue University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.


Credit Designation

Purdue University designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is acceptable for 1.5 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is 0482-9999-18-009-H02-P, effective 12/13/18. This is an application-based activity and there is no fee to attend.

This enduring material is approved for 1 year from the date of original release December 13, 2018 to December 12, 2019.


How to Participate in this Activity and Obtain CME/CPE Credit

To participate in this activity, you must read the objectives, answer the pretest questions, view the content, and complete the CME/CPE posttest and evaluation. Provide only 1 correct answer for each question. A satisfactory score is defined as answering 4 out of 6 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Purdue University will issue an AMA PRA Category 1 Credit(s)™ Certificate or Vindico Medical Education will issue an ACPE Continuing Education Credit(s) Certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education and Accreditation Council for Pharmacy Education’s Standards for Commercial Support, all CME/CPE providers are required to disclose to the activity audience the relevant financial relationships of the planners, faculty, and reviewers involved in the development of CME/CPE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME/CPE activity content over which the individual has control.  Relationship information appears below.


Activity Chair and Faculty report the following relationships

Richard A. Elion, MD
Consulting Fee: Gilead, ViiV
Speakers Bureau: Gilead, Janssen
Contracted Reasearch: Gilead Proteus

Joseph J. Eron, Jr., MD
Consulting Fee: Gilead, Janssen, Merck, ViiV
Contracted Research (paid to institution): Gilead, Janssen, ViiV

Paul E. Sax, MD
Consulting Fee: AbbVie, Bristol-Myers Squibb, Gilead, GlaxoSmithKline/ViiV, Janssen, Merck
Contracted Research (Paid to institution): Bristol-Myers Squibb, Gilead, GlaxoSmithKline/ViiV

Brian R. Wood, MD
No relevant financial relationships to disclose.


Reviewer reports the following relationship(s)

Jennifer Cocohoba, PharmD, MAS, BCPS, AAHIVP
No relevant financial relationships to disclose.


Purdue University and Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Purdue University and Vindico Medical Education, Offices of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Purdue University and Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of Purdue University and Vindico Medical Education. Neither Purdue University, Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com